Albendazole
- Product NDC
- 69539-151
- 11-digit product format
- 695390151
- Labeler code
- 69539
- Product ID
- 69539-151_9d29c5a2-af85-47b7-b59f-abf7f5ccaeb2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Albendazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- MSN LABORATORIES PRIVATE LIMITED
- Application
- ANDA213435
- Marketing category
- ANDA
- Marketing start
- 2021-01-25
- Marketing end
- 0000-00-00
- Substance
- ALBENDAZOLE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anthelmintic [EPC],Cytochrome P450 1A Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69539-151 | ALBENDAZOLE TABLET [MSN LABORATORIES PRIVATE LIMITED] | 2 | Legacy NDC | 20210126_f8e595be-a760-4d35-a6e9-34e0fdf95f2b.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69539-151-08 | 69539015108 | 2 TABLET in 1 BOTTLE (69539-151-08) | 2 tablet | 2021-01-25 | 0000-00-00 | No | No | Current |
| 69539-151-28 | 69539015128 | 28 TABLET in 1 BOTTLE (69539-151-28) | 28 tablet | 2021-01-25 | 0000-00-00 | No | No | Current |